Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm, officially known as China National Pharmaceutical Group, is the largest state-owned pharmaceutical and healthcare group in China, specializing in the research, manufacture, and distribution of pharmaceutical and healthcare products. The company operates a massive nationwide distribution network, serving as the primary distribution partner for numerous international life science companies seeking to enter the Chinese market. Beyond distribution, Sinopharm is a major manufacturer of vaccines, particularly known for its inactivated COVID-19 vaccines, and provides comprehensive services including retail pharmacy, logistics, and clinical research support. It plays a critical role in China's national healthcare infrastructure and pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on distribution partner in China.